Advent Technologies (ADN) Tops Q2 EPS by 2c

Go back to Advent Technologies (ADN) Tops Q2 EPS by 2c

Advent Technologies Reports Q2 2022 Results

August 9, 2022 7:00 AM EDT

Q2 revenue of $2.2 million, plus income from grants of $0.2 million, for a total of $2.4 million.  This compares to $1.1 million in the equivalent prior year period, representing a 124% increase.  Net loss in Q2 of $11.1 million or $0.22 per share. Company holds cash reserves of $46.5 million as of June 30, 2022. Notification from the Greek State for funding of 782.1 million under the Important Projects of Common European Interest (IPCEI) Hydrogen Technology for Advents Green HiPo project.  The notification was submitted from the Greek State to the European Union under the IPCEI framework and subsequently ratified by the... More